Aijaz Ahmed
Clinical Trials
- Not Recruiting PII of SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
- Not Recruiting Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
- Not Recruiting Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
- Not Recruiting Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease &Hepatocellular CA
- Recruiting Once-Daily Oral E5501 Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
Help